GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 107 filers reported holding GENMARK DIAGNOSTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $5,947,000 | -22.2% | 1,443,400 | -9.2% | 1.68% | +61.5% |
| Q4 2019 | $7,646,000 | +404.7% | 1,590,000 | +536.0% | 1.04% | +114.4% |
| Q3 2019 | $1,515,000 | +22.9% | 250,000 | +31.6% | 0.49% | +19.4% |
| Q2 2019 | $1,233,000 | -27.7% | 190,000 | -21.0% | 0.41% | -29.8% |
| Q1 2019 | $1,705,000 | +25.0% | 240,500 | -14.3% | 0.58% | +13.3% |
| Q4 2018 | $1,364,000 | -28.7% | 280,500 | +7.9% | 0.51% | -11.1% |
| Q3 2018 | $1,912,000 | +30.3% | 260,000 | +13.0% | 0.58% | +39.8% |
| Q2 2018 | $1,467,000 | +49.8% | 230,000 | +27.8% | 0.41% | +47.1% |
| Q1 2018 | $979,000 | +30.5% | 180,000 | 0.0% | 0.28% | +40.7% |
| Q4 2017 | $750,000 | +36.4% | 180,000 | +215.8% | 0.20% | +43.2% |
| Q3 2017 | $550,000 | -7.1% | 57,000 | +14.0% | 0.14% | -12.0% |
| Q2 2017 | $592,000 | – | 50,000 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 3,365,000 | $16,186,000 | 1.49% |
| CADIAN CAPITAL MANAGEMENT, LP | 5,517,767 | $26,540,000 | 1.17% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 1,590,000 | $7,646,000 | 1.04% |
| Parkman Healthcare Partners LLC | 420,000 | $2,020,000 | 0.58% |
| Penn Capital Management Company, LLC | 977,526 | $4,702,000 | 0.49% |
| Bullseye Asset Management LLC | 79,272 | $381,000 | 0.37% |
| Bellevue Group AG | 2,441,241 | $11,742,000 | 0.19% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 300,783 | $1,447,000 | 0.18% |
| Granite Investment Partners, LLC | 589,313 | $2,835,000 | 0.13% |
| WRAPMANAGER INC | 68,163 | $328,000 | 0.10% |